Drug Trial Radar · NCT03568331
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)
Last checked: Nov 19, 2026Latest source record: May 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
375
Actual
Start
Jul 9, 2018
Primary completion
Dec 27, 2019
Study completion Dec 27, 2019
Sponsor
- Lead sponsor
- Vanda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jun 26, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.
Conditions
- Atopic Dermatitis
Interventions
TradipitantDrug
Oral Capsule
PlaceboDrug
Oral Capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction of Worst Itch in Atopic DermatitisTime frame: 8 weeks
Locations
70 sites in 1 country. Site status is shown where the registry gives one.
Vanda Investigational Site
Birmingham, Alabama
Vanda Investigational Site
Birmingham, Alabama
Vanda Investigational Site
Tempe, Arizona
Vanda Investigational Site
Encino, California
Vanda Investigational Site
Fountain Valley, California
Vanda Investigational Site
Fremont, California
Vanda Investigational Site
Laguna Hills, California
Vanda Investigational Site
Lomita, California
Vanda Investigational Site
Long Beach, California
Vanda Investigational Site
Los Angeles, California
Vanda Investigational Site
Los Angeles, California
Vanda Investigational Site
San Diego, California
Vanda Investigational Site
Santa Monica, California
Vanda Investigational Site
Denver, Colorado
Vanda Investigational Site
Aventura, Florida
Vanda Investigational Site
Clearwater, Florida
Vanda Investigational Site
Fort Lauderdale, Florida
Vanda Investigational Site
Hialeah, Florida
Vanda Investigational Site
Miami, Florida
Vanda Investigational Site
Miami, Florida
Vanda Investigational Site
Miramar, Florida
Vanda Investigational Site
Ormond Beach, Florida
Vanda Investigational Site
South Miami, Florida
Vanda Investigational Site
Tampa, Florida
Vanda Investigational Site
Savannah, Georgia
Vanda Investigational Site
Boise, Idaho
Vanda Investigational Site
Normal, Illinois
Vanda Investigational Site
Skokie, Illinois
Vanda Investigational Site
Plainfield, Indiana
Vanda Investigational Site
Crowley, Louisiana
Vanda Investigational Site
Rockville, Maryland
Vanda Investigational Site
Towson, Maryland
Vanda Investigational Site
Beverly, Massachusetts
Vanda Investigational Site
Brighton, Massachusetts
Vanda Investigational Site
Fort Gratiot, Michigan
Vanda Investigational Site
Saint Joseph, Missouri
Vanda Investigational Site
St Louis, Missouri
Vanda Investigational Site
Omaha, Nebraska
Vanda Investigational Site
Las Vegas, Nevada
Vanda Investigational Site
Las Vegas, Nevada
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.